ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9 | -99.9% | 232 | +6.9% | 0.00% | – |
| Q3 2022 | $7,000 | -85.1% | 217 | -83.8% | 0.00% | – |
| Q2 2022 | $47,000 | -79.5% | 1,340 | -73.2% | 0.00% | -100.0% |
| Q1 2022 | $229,000 | -30.4% | 4,994 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $329,000 | +145.5% | 4,971 | +131.1% | 0.00% | +100.0% |
| Q3 2021 | $134,000 | +14.5% | 2,151 | +51.6% | 0.00% | 0.0% |
| Q2 2021 | $117,000 | -77.0% | 1,419 | -81.5% | 0.00% | -66.7% |
| Q1 2021 | $509,000 | +42.2% | 7,690 | +64.6% | 0.00% | 0.0% |
| Q4 2020 | $358,000 | +79.9% | 4,672 | +1.0% | 0.00% | +50.0% |
| Q3 2020 | $199,000 | +26.8% | 4,626 | +27.6% | 0.00% | 0.0% |
| Q2 2020 | $157,000 | +70.7% | 3,626 | +13.3% | 0.00% | +100.0% |
| Q1 2020 | $92,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |